Literature DB >> 2903293

Treatment of acute graft-versus-host disease with monoclonal antibody to IL-2 receptor.

P Hervé, J Wijdenes, J P Bergerat, N Milpied, C Gaud, P Bordigoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903293     DOI： 10.1016/s0140-6736(88)90085-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction.

Authors:  H J Deeg
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

2.  Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptor.

Authors:  D W Beelen; H Grosse-Wilde; U Ryschka; K Quabeck; H G Sayer; U Graeven; U W Schaefer
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.